Hematopoietic stem cell origin of mesenchymal cells: opportunity for novel therapeutic approaches |
| |
| Authors: | Makio Ogawa Amanda C LaRue Patricia M Watson Dennis K Watson |
| |
| Affiliation: | (1) Department of Pathology and Laboratory Medicine, VA Medical Center, Medical University of South Carolina, 109 Bee Street, Charleston, SC 29412, USA;(2) Department of Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA;(3) Department of Pathology and Laboratory Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA;(4) Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA |
| |
| Abstract: | There has been a general belief that there are two types of adult stem cells, i.e., hematopoietic stem cells (HSCs) and mesenchymal
stem cells (MSCs), each with distinctly different functions. According to this dogma, HSCs produce blood cells, while MSCs
are thought to generate a number of non-hematopoietic cells including fibroblasts, adipocytes, chondrocytes and bone cells.
Recently, a number of studies, including those in our laboratory based on single HSC transplantation, blurred the clear distinction
between HSCs and MSCs and strongly suggested an HSC origin of the adult mesenchymal tissues. This review summarizes the experimental
evidence for this new paradigm and the literature pointing out the vagary in the stem cell nature of MSCs. The concept of
the HSC origin of mesenchymal cells will have many immediate and long-term impacts on the therapies of diseases and injuries
of the connective tissues. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
